Long-Term Effects of Fenofibrate on Carotid Intima-Media Thickness and Augmentation Index in Subjects With Type 2 Diabetes Mellitus

This publication has 36 references indexed in Scilit:

• Efficacy of cholesterol-lowering therapy in 18 686 people with diabetes in 14 randomised trials of statins: a meta-analysis
  Published by Elsevier ,2008
• The Reduction of Inflammatory Biomarkers by Statin, Fibrate, and Combination Therapy Among Diabetic Patients With Mixed Dyslipidemia
  Journal of the American College of Cardiology, 2006
• Type 2 Diabetes as a “Coronary Heart Disease Equivalent”
  Diabetes Care, 2005
• Effect of Atorvastatin and Irbesartan, Alone and in Combination, on Postprandial Endothelial Dysfunction, Oxidative Stress, and Inflammation in Type 2 Diabetic Patients
  Circulation, 2005
• HMG-CoA Reductase Inhibitors Suppress the Development and Progression of Carotid Artery Intimal-medial Thickening in Hypercholesterolemic Type 2 Diabetic Patients
  Journal of Atherosclerosis and Thrombosis, 2005
• Effect of Atorvastatin on Regional Arterial Stiffness in Patients with Type 2 Diabetes Mellitus
  Journal of Atherosclerosis and Thrombosis, 2005
• Strong decrease of high sensitivity C-reactive protein with high-dose atorvastatin in patients with type 2 diabetes mellitus
  Atherosclerosis, 2003
• Evidence for an Independent and Cumulative Effect of Postprandial Hypertriglyceridemia and Hyperglycemia on Endothelial Dysfunction and Oxidative Stress Generation
  Circulation, 2002
• Atorvastatin Lowers C-Reactive Protein and Improves Endothelium-Dependent Vasodilation in Type 2 Diabetes Mellitus
  Journal of Clinical Endocrinology & Metabolism, 2002
• Mortality from Coronary Heart Disease in Subjects with Type 2 Diabetes and in Nondiabetic Subjects with and without Prior Myocardial Infarction
  New England Journal of Medicine, 1998